Recruiting at 1 site No phase Cardiovascular Disease Prevention

Cardiovascular Disease Prevention study: Longitudinal

Official title Preventative Screening and Health Coaching in a Food Insecure Population

ClinicalTrials.gov ID: NCT06907524

What this study is testing

What it's testing
The study aims to find out if regular virtual coaching on diet and exercise reduces the risk of heart attack, stroke, high blood pressure, high cholesterol, and diabetes.
Who it's for
The study is looking for people who do not always have enough food to eat and are at risk for heart or metabolic diseases.
What's involved
Participants will attend in-person health screenings at the start, month 3, and month 6. They will also join virtual coaching sessions to discuss diet, exercise, and blood pressure, and keep a log of their blood pressure readings.
Time commitment
The study lasts six months and requires three in-person visits plus regular virtual coaching sessions.
  • Time commitment: about 9 years

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 40 to 75

You may be able to join if

  • Patient is a participant at a CHI sponsored, community screening event
  • Patient provides informed consent and willingness to participate for the duration of the study
  • English or Spanish speaking
  • Age 40-75 years old
  • Systolic BP greater than 130mmHg and/or diastolic BP greater than 80mmHg.
See the full eligibility criteria
Who can join
  • Patient is a participant at a CHI sponsored, community screening event
  • Patient provides informed consent and willingness to participate for the duration of the study
  • English or Spanish speaking
  • Age 40-75 years old
  • Systolic BP greater than 130mmHg and/or diastolic BP greater than 80mmHg.
  • Body mass index (BMI) greater than 30 〖kg/m〗\^2
  • Total cholesterol greater than 200 mg/dL
  • Triglycerides greater than 150 mg/dL
  • Low density lipoprotein (LDL) greater than 130 mg/dL
  • High density lipoprotein (HDL) less than 40 mg/dL in men or less than 50 mg/dL in women
  • Hemoglobin A1c greater than or equal to 5.7%
  • 10-year ASCVD score greater than 5%
  • Adults unable to provide informed consent or unwilling to participate for study duration
  • Speaks language other than English or Spanish
  • Younger than 40 years old or older than 75 years old
  • All cardiometabolic risk factors at optimal levels
  • No telehealth compatible device
  • Pregnant patients

The study team makes the final eligibility decision.

Where it is enrolling

  • Chicago, Illinois, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The study runs about 9 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling all sexes, 40 years to 75 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Chicago, Illinois, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.